ASTRAZENECA PHARMA INDIA LIMITED

Press Releases AstraZeneca Pharma India Limited NSE India S.E.

Equities

ASTRAZEN

INE203A01020

Delayed NSE India S.E. Other stock markets 04:50:57 2024-05-22 EDT			5-day change	1st Jan Change
5,757 ^INR	-0.45%		+4.84%	+4.17%

04-08	AstraZeneca Pharma India Limited Approves Appointment of Bhavana Agrawal as Director and Whole Time Director	CI
03-25	AstraZeneca Pharma India Limited Appoints Vinay Sharma as Business Unit Head - Rare Disease, Effective July 1, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AstraZeneca Pharma India : Certificate under SEBI (Depositories and Participants) Regulations, 2018	23-01-14	PU
AstraZeneca Pharma India : Annual General Meeting	22-07-15	PU
AstraZeneca Pharma India : Schedule of Analysts/Institutional Investor Meet/Con. Call	22-07-01	PU
AstraZeneca Pharma India : Postal Ballot	22-02-23	PU
SEBI Order: AstraZeneca Pharma And The Elliott Group	20-06-19	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW